Breaking Out: Regenerative medicine play Orthocell’s run might just be getting started
Breaking Out is a technical analysis-fuelled, short ‘n’ sharp take on chart-busting ASX stocks. Each week, Steve Collette – head of Collette Capital in Melbourne – narrows in on something that’s caught his eye. Orthocell appears determined to end 2024 on …